|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
|
Zenith Epigenetics
|
Jan 27, 2023 09:43AM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
1
|
Zenith Epigenetics
|
Jan 26, 2023 01:08PM
|
|
Re: Some history
|
2
|
Resverlogix Corp.
|
Jan 25, 2023 02:10PM
|
|
Re: Some history
|
1
|
Resverlogix Corp.
|
Jan 25, 2023 01:33PM
|
|
Re: Some history
|
2
|
Resverlogix Corp.
|
Jan 25, 2023 01:21PM
|
|
Re: Some history
|
1
|
Resverlogix Corp.
|
Jan 25, 2023 12:19PM
|
|
Re: IR
|
2
|
Resverlogix Corp.
|
Jan 18, 2023 02:56PM
|
|
Re: Another quarter and not a peep
|
3
|
Resverlogix Corp.
|
Jan 04, 2023 12:09PM
|
|
Hub Leaders
|
4
|
Zenith Epigenetics
|
Dec 26, 2022 09:36AM
|
|
Re: Update from IR -- Eversana paused?
|
1
|
Resverlogix Corp.
|
Dec 22, 2022 12:41PM
|
|
Re: Update from IR -- Eversana paused?
|
2
|
Resverlogix Corp.
|
Dec 22, 2022 11:32AM
|
|
Re: from IR/Chris
|
1
|
Zenith Epigenetics
|
Dec 15, 2022 02:25PM
|
|
Re: from IR/Chris
|
2
|
Zenith Epigenetics
|
Dec 15, 2022 01:54PM
|
|
Re: 6%
|
|
Zenith Epigenetics
|
Dec 15, 2022 10:39AM
|
|
Re: 6%
|
|
Zenith Epigenetics
|
Dec 15, 2022 10:11AM
|
|
6%
|
2
|
Zenith Epigenetics
|
Dec 14, 2022 02:52PM
|
|
RE: TFSA
|
2
|
Zenith Epigenetics
|
Nov 24, 2022 04:01PM
|
|
Re: OTC Expert & Grey Market Restrictions
|
|
Zenith Epigenetics
|
Nov 22, 2022 04:29PM
|
|
Re: OTC Expert & Grey Market Restrictions
|
|
Zenith Epigenetics
|
Nov 22, 2022 03:48PM
|
|
Re: OTC Expert & Grey Market Restrictions
|
|
Zenith Epigenetics
|
Nov 22, 2022 03:24PM
|
